世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

等温核酸増幅技術市場：製品（アッセイ、システム）、技術（LAMP、SDA、NASBA、NEAR、HDA）、用途（診断薬（インフルエンザ、肝炎、CT/NG、COVID-19）、血液スクリーニング）、エンドユーザー＆地域別 - 2028年までの世界予測


Isothermal Nucleic Acid Amplification Technology Market by Product (Assay, System), Technology (LAMP, SDA, NASBA, NEAR, HDA), Application (Diagnostics (Influenza, Hepatitis, CT/NG, COVID-19), blood screening), End User & Region - Global Forecast to 2028

等温核酸増幅技術市場は、2023年の44億米ドルから2028年には68億米ドルに達すると予測され、予測期間中のCAGRは9.2%に達すると予測されます。感染症の有病率の増加、INAAT製品の発売と承認、診断ツールへの資金提... もっと見る

　

　

出版社 出版年月 電子版価格 ページ数 図表数 言語
MarketsandMarkets
マーケッツアンドマーケッツ 		2023年3月8日 US$4,950
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら 		226 272 英語

日本語のページは自動翻訳を利用し作成しています。


　

サマリー

等温核酸増幅技術市場は、2023年の44億米ドルから2028年には68億米ドルに達すると予測され、予測期間中のCAGRは9.2%に達すると予測されます。感染症の有病率の増加、INAAT製品の発売と承認、診断ツールへの資金提供の可能性は、等温核酸増幅技術市場の成長を促進する様々な要因であると予測されます。
INAAT市場で最も大きなシェアを占めるLAMPセグメント
技術に基づき、等温核酸増幅技術市場は、ループ媒介等温増幅（LAMP）、転写媒介増幅（TMA）、鎖置換増幅（SDA）、ニッキング酵素増幅反応（NEAR）、シングルプライマー等温増幅（SPIA）、その他の技術に分類されます。2022年には、ループ媒介等温増幅法（LAMP）セグメントが市場を支配しました。これは、LAMPキットの需要が高く、世界中の先進国および発展途上国市場で広く利用可能であることに起因しています。
感染症診断分野が市場の最大用途分野を占める
INAAT市場は、アプリケーションに基づき、感染症診断、血液スクリーニング、その他のアプリケーションに分類されます。2022年には、疾患診断分野が市場を支配すると予想されます。このセグメントの成長を促進するさまざまな要因は、世界的なHIV、インフルエンザ、肝炎の患者数の増加、感染症対策への注力、これらの疾患の診断のためのINAATベースのキットの使用です。

等温核酸増幅技術市場の有力企業は、Grifols, S.A.（スペイン）、Hologic, Inc.（米国）、Abbott Laboratories（米国）、Becton, Dickinson and Company（米国）、Meridian Bioscience（米国）、栄研化学株式会社、株式会社エーアイエヌシー（日本）、bioMérieux SA（フランス）、Tecan Trading AG（スイス）、New England Biolabs（米国）、QIAGEN N.V.（ドイツ）、DiaSorin Inc.(日本）、bioMérieux SA（フランス）、Tecan Trading AG（スイス）、New England Biolabs（米国）、QIAGEN N.V.（ドイツ）、DiaSorin S.p.A（イタリア）、General Electric（米国）、OptiGene Limited（イギリス）、Quidel Corporation（アメリカ）、 Thermo Fisher Scientific（アメリカ）、Genomtec（ポーランド）、Mast Group Ltd.(英国）、Ustar Biotechnologies（中国）、Jena Bioscience GmbH（ドイツ）、Atila BioSystems（米国）、TwistDx Limited（英国）、LGC Limited（英国）、Life Sciences Advanced Technologies（米国）、GenoSensor Corporation（米国）、PCR Biosystems（英国）です。

"北米で等温核酸増幅技術市場において最大のシェアを占める"
等温核酸増幅技術市場は、北米が最大のシェアを占めています。研究資金の確保や診断産業の発展、HIV、肝炎、インフルエンザ患者の早期診断の重要性の高まり、医療インフラの整備などの要因が、市場成長を促す主な要因となっています。
本レポートのために実施した一次インタビューは、以下のように分類されます：

- 回答者別供給側：80％、需要側：20
- 役職別マネージャー45％、CXO・ディレクタークラス30％、エグゼクティブ25％。
- 地域別北米：20％、欧州：15％、アジア太平洋：55％、RoW：10％。
レポート掲載企業一覧
- Grifols, S.A.(スペイン)
- ホロジック社(米国)
- アボット・ラボラトリーズ（米国）
- ベクトン・ディッキンソン・アンド・カンパニー（米国）
- メリディアンバイオサイエンス（米国）
- 栄研化学株式会社(日本)
- bioMérieux SA（フランス）
- テカントレーディングAG（スイス）
- ニューイングランド・バイオラボス（米国）
- QIAGEN N.V.(ドイツ)
- DiaSorin S.p.A.（イタリア）
- ゼネラル・エレクトリック（米国）
- オプティジーン社（英国）
- クィデル・コーポレーション（米国）
- サーモフィッシャーサイエンティフィック（米国）
- ジェノムテック社（ポーランド）
- マスト・グループ・リミテッド(イギリス)
- ユースターバイオテクノロジーズ（中国）
- イエナ・バイオサイエンス社（ドイツ）
- アティラ・バイオシステムズ（米国）
- ツイストデクス社（英国）
- LGCリミテッド（英国）
- ライフサイエンス・アドバンスト・テクノロジーズ（米国）
- ジェノセンサー社（米国）
- PCRバイオシステムズ社（英国）

調査対象です：
本レポートは、等温核酸増幅技術市場の詳細な情報を提供します。製品、用途、エンドユーザー、地域などの異なるセグメントにおける市場規模および今後の成長可能性を推定することを目的としています。また、主要な市場プレイヤーの会社概要や最近の開発状況、主要な市場戦略とともに、詳細な競合分析も掲載しています。
レポートを購入する主な利点
本レポートは、等温核酸増幅技術市場全体とそのサブセグメントにおける収益数の最も近い近似値を提供することで、市場リーダー／新規参入者の助けとなります。また、利害関係者が競争環境をよりよく理解し、より多くの洞察を得ることで、自社のビジネスをよりよく位置づけ、適切な市場参入戦略を立てることができるようになるでしょう。本レポートは、関係者が市場の脈絡を理解し、主要な市場促進要因、阻害要因、課題、および機会に関する情報を提供することを可能にします。

ページTOPに戻る


目次

1 INTRODUCTION 34
1.1 STUDY OBJECTIVES 34
1.2 MARKET DEFINITION 34
1.2.1 INCLUSIONS & EXCLUSIONS 35
1.3 MARKET SCOPE 36
FIGURE 1 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SEGMENTATION 36
1.3.1 YEARS CONSIDERED 37
1.4 CURRENCY CONSIDERED 37
1.5 LIMITATIONS 37
1.6 STAKEHOLDERS 38
1.7 SUMMARY OF CHANGES 38
2 RESEARCH METHODOLOGY 39
2.1 RESEARCH APPROACH 39
FIGURE 2 RESEARCH DESIGN 39
2.1.1 PRIMARY RESEARCH 39
FIGURE 3 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: PRIMARY RESPONDENTS 40
2.2 MARKET ESTIMATION METHODOLOGY 40
FIGURE 4 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS, 2022 40
FIGURE 5 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2022 41
2.2.1 INSIGHTS FROM PRIMARY EXPERTS 42
FIGURE 6 MARKET SIZE VALIDATION FROM PRIMARY RESOURCES 42
2.3 MARKET GROWTH RATE PROJECTIONS 43
FIGURE 7 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: CAGR PROJECTIONS, 2023–2028 44
FIGURE 8 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET (DEMAND SIDE): GROWTH ANALYSIS OF DEMAND-SIDE FACTORS 44
2.4 DATA TRIANGULATION 45
FIGURE 9 DATA TRIANGULATION METHODOLOGY 45
2.5 RESEARCH ASSUMPTIONS 45
2.6 RISK ANALYSIS 46
2.7 RECESSION IMPACT 46
3 EXECUTIVE SUMMARY 48
FIGURE 10 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION) 48
FIGURE 11 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION) 49
FIGURE 12 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 49
FIGURE 13 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 50
FIGURE 14 GEOGRAPHICAL SNAPSHOT OF ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET 51
4 PREMIUM INSIGHTS 52
4.1 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET OVERVIEW 52
FIGURE 15 INCREASING PREVALENCE OF INFECTIOUS DISEASES TO DRIVE MARKET GROWTH 52
4.2 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT AND COUNTRY (2022) 53
FIGURE 16 ASSAYS, KITS, AND REAGENTS ACCOUNTED FOR LARGEST MARKET SHARE IN 2022 53
4.3 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SHARE, BY APPLICATION, 2023 VS. 2028 53
FIGURE 17 DISEASE DIAGNOSIS APPLICATION SEGMENT TO CONTINUE TO DOMINATE MARKET IN 2028 53
4.4 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 54
FIGURE 18 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 54
5 MARKET OVERVIEW 55
5.1 INTRODUCTION 55
5.2 MARKET DYNAMICS 55
FIGURE 19 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 55
TABLE 1 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 56
5.2.1 DRIVERS 56
5.2.1.1 Recent launches of INAAT consumables by prominent market players 56
5.2.1.2 Growing funding initiatives for molecular diagnostics & infectious disease diagnostics 57
5.2.1.3 High prevalence of infectious diseases 58
5.2.2 RESTRAINTS 58
5.2.2.1 Unfavorable reimbursement scenario for in vitro diagnostic tests 58
5.2.3 OPPORTUNITIES 59
5.2.3.1 INAAT tests as point-of-care tools 59
5.2.3.2 Start-ups focusing on INAAT 59
5.2.4 CHALLENGES 60
5.2.4.1 Dominance of PCR 60
5.3 PRICING ANALYSIS 60
TABLE 2 AVERAGE SELLING PRICE OF INAAT PRODUCTS, 2022 60
5.4 VALUE CHAIN ANALYSIS 61
FIGURE 20 VALUE CHAIN OF INAAT MARKET: MAXIMUM VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES 61
5.5 ECOSYSTEM ANALYSIS 62
FIGURE 21 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: ECOSYSTEM ANALYSIS 62
TABLE 3 SUPPLY CHAIN ECOSYSTEM 63
5.6 KEY CONFERENCES & EVENTS IN 2023–2024 63
TABLE 4 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: DETAILED LIST OF CONFERENCES & EVENTS 63
5.7 PORTER’S FIVE FORCES ANALYSIS 65
TABLE 5 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: PORTER’S FIVE FORCES ANALYSIS 65
5.7.1 THREAT FROM NEW ENTRANTS 65
5.7.2 THREAT FROM SUBSTITUTES 65
5.7.3 BARGAINING POWER OF BUYERS 65
5.7.4 BARGAINING POWER OF SUPPLIERS 65
5.7.5 DEGREE OF COMPETITION 66
5.8 KEY STAKEHOLDERS & BUYING CRITERIA 66
FIGURE 22 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF INAAT PRODUCTS 66
FIGURE 23 BUYING CRITERIA FOR INAAT PRODUCTS 66
5.9 PATENT ANALYSIS 67
FIGURE 24 PATENT APPLICATIONS RELATED TO ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, JANUARY 2012–DECEMBER 2022 67
5.10 REGULATORY ANALYSIS 67
TABLE 6 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 67
TABLE 7 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 68
TABLE 8 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 68
TABLE 9 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 68
5.10.1 NORTH AMERICA 69
5.10.1.1 US 69
5.10.1.2 Canada 69
5.10.2 EUROPE 69
TABLE 10 EUROPE: CLASSIFICATION OF DEVICES 69
5.10.3 ASIA PACIFIC 70
5.10.3.1 China 70
5.10.3.2 Japan 70
5.10.3.3 India 70
5.10.4 LATIN AMERICA 70
5.10.4.1 Brazil 70
5.10.4.2 Mexico 71
5.10.5 MIDDLE EAST 71
5.11 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 71
FIGURE 25 REVENUE SHIFT AND NEW REVENUE POCKETS 71
6 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT 72
6.1 INTRODUCTION 73
TABLE 11 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 73
6.2 ASSAYS, KITS, AND REAGENTS 73
6.2.1 GROWING AWARENESS OF INAAT TO DRIVE DEMAND FOR ASSAYS, KITS, AND REAGENTS 73
TABLE 12 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY ASSAYS, KITS, AND REAGENTS MARKET, BY REGION, 2021–2028 (USD MILLION) 74
TABLE 13 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY ASSAYS, KITS, AND REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 74
TABLE 14 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY ASSAYS, KITS, AND REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 74
TABLE 15 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY ASSAYS, KITS, AND REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 75
6.3 SYSTEMS 75
6.3.1 GROWING POPULARITY OF INAAT SYSTEMS TO SUPPORT MARKET GROWTH 75
TABLE 16 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 76
TABLE 17 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 76
TABLE 18 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 76
TABLE 19 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 77
7 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY 78
7.1 INTRODUCTION 79
TABLE 20 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGIES 79
TABLE 21 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 80
7.2 LOOP-MEDIATED ISOTHERMAL AMPLIFICATION (LAMP) 80
7.2.1 LAUNCH OF NEW LAMP DIAGNOSTIC KITS TO SUPPORT MARKET GROWTH 80
TABLE 22 LOOP-MEDIATED ISOTHERMAL AMPLIFICATION (LAMP) MARKET, BY REGION, 2021–2028 (USD MILLION) 81
TABLE 23 NORTH AMERICA: LOOP-MEDIATED ISOTHERMAL AMPLIFICATION (LAMP) MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 81
TABLE 24 EUROPE: LOOP-MEDIATED ISOTHERMAL AMPLIFICATION (LAMP) MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 82
TABLE 25 ASIA PACIFIC: LOOP-MEDIATED ISOTHERMAL AMPLIFICATION (LAMP) MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 82
7.3 TRANSCRIPTION-MEDIATED AMPLIFICATION (TMA) 82
7.3.1 GROWING EFFORTS TO DEVELOP TMA KITS TO BOOST GROWTH 82
TABLE 26 TRANSCRIPTION-MEDIATED AMPLIFICATION (TMA) MARKET, BY REGION, 2021–2028 (USD MILLION) 83
TABLE 27 NORTH AMERICA: TRANSCRIPTION-MEDIATED AMPLIFICATION (TMA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 83
TABLE 28 EUROPE: TRANSCRIPTION-MEDIATED AMPLIFICATION (TMA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 84
TABLE 29 ASIA PACIFIC: TRANSCRIPTION-MEDIATED AMPLIFICATION (TMA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 84
7.4 NICKING ENZYME AMPLIFICATION REACTION (NEAR) 84
7.4.1 RAPID IDENTIFICATION OF SMALL DNA OR RNA FRAGMENTS TO BOOST ADOPTION OF NEAR 84
TABLE 30 NICKING ENZYME AMPLIFICATION REACTION (NEAR) MARKET, BY REGION, 2021–2028 (USD MILLION) 85
TABLE 31 NORTH AMERICA: NICKING ENZYME AMPLIFICATION REACTION (NEAR) MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 85
TABLE 32 EUROPE: NICKING ENZYME AMPLIFICATION REACTION (NEAR) MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 86
TABLE 33 ASIA PACIFIC: NICKING ENZYME AMPLIFICATION REACTION (NEAR) MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 86
7.5 STRAND DISPLACEMENT AMPLIFICATION (SDA) 86
7.5.1 GROWING USE OF SDA IN RNA AMPLIFICATION TO PROPEL MARKET GROWTH 86
TABLE 34 STRAND DISPLACEMENT AMPLIFICATION (SDA) MARKET, BY REGION, 2021–2028 (USD MILLION) 87
TABLE 35 NORTH AMERICA: STRAND DISPLACEMENT AMPLIFICATION (SDA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 87
TABLE 36 EUROPE: STRAND DISPLACEMENT AMPLIFICATION (SDA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 88
TABLE 37 ASIA PACIFIC: STRAND DISPLACEMENT AMPLIFICATION (SDA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 88
7.6 HELICASE-DEPENDENT AMPLIFICATION (HDA) 88
7.6.1 USE OF THERMOSTABLE HELICASE ENZYMES INSTEAD OF HEAT TO BOOST DEMAND FOR HDA 88
TABLE 38 HELICASE-DEPENDENT AMPLIFICATION (HDA) MARKET, BY REGION, 2021–2028 (USD MILLION) 89
TABLE 39 NORTH AMERICA: HELICASE-DEPENDENT AMPLIFICATION (HDA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 89
TABLE 40 EUROPE: HELICASE-DEPENDENT AMPLIFICATION (HDA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 90
TABLE 41 ASIA PACIFIC: HELICASE-DEPENDENT AMPLIFICATION (HDA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 90
7.7 NUCLEIC ACID SEQUENCE-BASED AMPLIFICATION (NASBA) 90
7.7.1 ADVANTAGES OF NASBA OVER PCR TO BOOST ADOPTION IN CLINICAL SETTINGS 90
TABLE 42 NUCLEIC ACID SEQUENCE-BASED AMPLIFICATION (NASBA) MARKET, BY REGION, 2021–2028 (USD MILLION) 91
TABLE 43 NORTH AMERICA: NUCLEIC ACID SEQUENCE-BASED AMPLIFICATION (NASBA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 91
TABLE 44 EUROPE: NUCLEIC ACID SEQUENCE-BASED AMPLIFICATION (NASBA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 92
TABLE 45 ASIA PACIFIC: NUCLEIC ACID SEQUENCE-BASED AMPLIFICATION (NASBA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 92
7.8 SINGLE-PRIMER ISOTHERMAL AMPLIFICATION (SPIA) 92
7.8.1 USE OF RNA/DNA-3′ PRIMER FOR FIRST-STRAND CDNA SYNTHESIS TO DRIVE MARKET 92
TABLE 46 SINGLE-PRIMER ISOTHERMAL AMPLIFICATION (SPIA) MARKET, BY REGION, 2021–2028 (USD MILLION) 93
TABLE 47 NORTH AMERICA: SINGLE-PRIMER ISOTHERMAL AMPLIFICATION (SPIA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 93
TABLE 48 EUROPE: SINGLE-PRIMER ISOTHERMAL AMPLIFICATION (SPIA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 94
TABLE 49 ASIA PACIFIC: SINGLE-PRIMER ISOTHERMAL AMPLIFICATION (SPIA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 94
7.9 OTHER TECHNOLOGIES 95
TABLE 50 OTHER INAAT TECHNOLOGIES MARKET, BY REGION, 2021–2028 (USD MILLION) 95
TABLE 51 NORTH AMERICA: OTHER INAAT TECHNOLOGIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 95
TABLE 52 EUROPE: OTHER INAAT TECHNOLOGIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 96
TABLE 53 ASIA PACIFIC: OTHER INAAT TECHNOLOGIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 96
8 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION 97
8.1 INTRODUCTION 98
TABLE 54 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 98
8.2 DISEASE DIAGNOSIS 98
TABLE 55 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 98
TABLE 56 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 99
TABLE 57 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 99
TABLE 58 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 99
TABLE 59 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 100
8.2.1 COVID-19 100
8.2.1.1 Extensive use of INAAT kits for COVID-19 diagnosis to support market growth 100
TABLE 60 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR COVID-19 TESTING, BY REGION, 2021–2028 (USD MILLION) 101
TABLE 61 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR COVID-19 TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 101
TABLE 62 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR COVID-19 TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 101
TABLE 63 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR COVID-19 TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 102
8.2.2 HEPATITIS 102
8.2.2.1 Growing adoption of advanced technologies for diagnosis of hepatitis B to drive growth 102
FIGURE 26 NEW CASES OF HEPATITIS B AND HEPATITIS C WORLDWIDE, BY GENDER, 2020 102
TABLE 64 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HEPATITIS TESTING, BY REGION, 2021–2028 (USD MILLION) 103
TABLE 65 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HEPATITIS TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 103
TABLE 66 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HEPATITIS TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 103
TABLE 67 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HEPATITIS TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 104
8.2.3 CT/NG 104
8.2.3.1 Growing prevalence of CT/NG infections worldwide to boost market 104
TABLE 68 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR CT/NG TESTING, BY REGION, 2021–2028 (USD MILLION) 105
TABLE 69 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR CT/NG TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 105
TABLE 70 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR CT/NG TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 105
TABLE 71 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR CT/NG TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 106
8.2.4 INFLUENZA 106
8.2.4.1 Growing focus on containing spread of influenza to propel growth 106
TABLE 72 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR INFLUENZA TESTING, BY REGION, 2021–2028 (USD MILLION) 106
TABLE 73 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR INFLUENZA TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 107
TABLE 74 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR INFLUENZA TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 107
TABLE 75 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR INFLUENZA TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 107
8.2.5 HIV 108
8.2.5.1 High global incidence of HIV to support market growth 108
TABLE 76 GLOBAL HIV CASES, 2021 108
TABLE 77 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HIV TESTING, BY REGION, 2021–2028 (USD MILLION) 108
TABLE 78 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HIV TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 109
TABLE 79 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HIV TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 109
TABLE 80 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HIV TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 109
8.2.6 OTHER DISEASES 110
TABLE 81 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER DISEASES, BY REGION, 2021–2028 (USD MILLION) 110
TABLE 82 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER DISEASES, BY COUNTRY, 2021–2028 (USD MILLION) 110
TABLE 83 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER DISEASES, BY COUNTRY, 2021–2028 (USD MILLION) 111
TABLE 84 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER DISEASES, BY COUNTRY, 2021–2028 (USD MILLION) 111
8.3 BLOOD SCREENING 111
8.3.1 INCREASING NUMBER OF BLOOD DONATIONS AND TRANSFUSIONS TO INCREASE USE OF INAAT IN BLOOD SCREENING APPLICATIONS 111
TABLE 85 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR BLOOD SCREENING APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 112
TABLE 86 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR BLOOD SCREENING APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 112
TABLE 87 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR BLOOD SCREENING APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 113
TABLE 88 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR BLOOD SCREENING APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 113
8.4 OTHER APPLICATIONS 113
TABLE 89 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 114
TABLE 90 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 114
TABLE 91 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 114
TABLE 92 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 115
9 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER 116
9.1 INTRODUCTION 117
TABLE 93 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION) 117
9.2 HOSPITALS 117
9.2.1 HOSPITALS TO DOMINATE INAAT MARKET DURING FORECAST PERIOD 117
TABLE 94 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HOSPITALS, BY REGION, 2021–2028 (USD MILLION) 118
TABLE 95 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION) 118
TABLE 96 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION) 118
TABLE 97 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION) 119
9.3 REFERENCE LABORATORIES 119
9.3.1 AVAILABILITY OF WIDE RANGE OF TEST PANELS FOR INFECTIOUS DISEASE TESTING TO SUPPORT MARKET 119
TABLE 98 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR REFERENCE LABORATORIES, BY REGION, 2021–2028 (USD MILLION) 119
TABLE 99 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 120
TABLE 100 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 120
TABLE 101 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 120
9.4 ACADEMIC & RESEARCH INSTITUTES 121
9.4.1 GROWING USE OF INAAT ASSAYS BY ACADEMIC & RESEARCH INSTITUTES TO BOOST MARKET 121
TABLE 102 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION) 121
TABLE 103 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 121
TABLE 104 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 122
TABLE 105 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 122
9.5 OTHER END USERS 122
TABLE 106 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION) 123
TABLE 107 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 123
TABLE 108 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 123
TABLE 109 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 124
10 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY REGION 125
10.1 INTRODUCTION 126
TABLE 110 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY REGION, 2021–2028 (USD MILLION) 126
10.2 NORTH AMERICA 126
FIGURE 27 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SNAPSHOT 127
TABLE 111 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 127
TABLE 112 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 128
TABLE 113 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 128
TABLE 114 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 129
TABLE 115 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 129
TABLE 116 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION) 129
10.2.1 US 130
10.2.1.1 Increasing approvals of INAAT products to drive market growth 130
TABLE 117 US: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 130
TABLE 118 US: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 131
TABLE 119 US: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 131
TABLE 120 US: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 132
TABLE 121 US: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION) 132
10.2.2 CANADA 132
10.2.2.1 Growing demand for molecular diagnostic kits to boost adoption of INAAT 132
TABLE 122 CANADA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 133
TABLE 123 CANADA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 133
TABLE 124 CANADA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 134
TABLE 125 CANADA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 134
TABLE 126 CANADA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION) 134
10.2.3 NORTH AMERICA: RECESSION IMPACT 135
10.3 EUROPE 135
TABLE 127 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 136
TABLE 128 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 136
TABLE 129 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 137
TABLE 130 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 137
TABLE 131 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 138
TABLE 132 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION) 138
10.3.1 GERMANY 138
10.3.1.1 Germany to dominate European isothermal nucleic acid amplification technology market during forecast period 138
TABLE 133 GERMANY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 139
TABLE 134 GERMANY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 140
TABLE 135 GERMANY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 140
TABLE 136 GERMANY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 141
TABLE 137 GERMANY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION) 141
10.3.2 UK 141
10.3.2.1 Growing adoption of INAAT products to support market growth in UK 141
TABLE 138 NUMBER OF BLOOD DONATIONS IN UK, 2016–2020 142
TABLE 139 UK: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 142
TABLE 140 UK: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 143
TABLE 141 UK: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 143
TABLE 142 UK: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 144
TABLE 143 UK: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION) 144
10.3.3 FRANCE 144
10.3.3.1 Established blood screening regulations to boost growth 144
TABLE 144 HIV DATA FOR FRANCE, 2021 145
TABLE 145 FRANCE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 145
TABLE 146 FRANCE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 145
TABLE 147 FRANCE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 146
TABLE 148 FRANCE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 146
TABLE 149 FRANCE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION) 146
10.3.4 ITALY 147
10.3.4.1 Favorable government initiatives for blood transfusion to support growth 147
TABLE 150 HIV DATA FOR ITALY, 2021 147
TABLE 151 ITALY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 148
TABLE 152 ITALY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 148
TABLE 153 ITALY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 149
TABLE 154 ITALY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 149
TABLE 155 ITALY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION) 149
10.3.5 SPAIN 150
10.3.5.1 Growing demand for diagnostic testing in Spain to favor market growth 150
TABLE 156 HIV DATA FOR SPAIN, 2021 150
TABLE 157 SPAIN: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 151
TABLE 158 SPAIN: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 151
TABLE 159 SPAIN: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 152
TABLE 160 SPAIN: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 152
TABLE 161 SPAIN: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION) 152
10.3.6 REST OF EUROPE 153
TABLE 162 REST OF EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 153
TABLE 163 REST OF EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 154
TABLE 164 REST OF EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 154
TABLE 165 REST OF EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 155
TABLE 166 REST OF EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION) 155
10.3.7 EUROPE: RECESSION IMPACT 155

　

ページTOPに戻る


　

Summary

The isothermal nucleic acid amplification technology market is projected to reach USD 6.8 Billion by 2028 from USD 4.4 Billion in 2023, at a CAGR of 9.2% during the forecast period. Increasing prevalence of infectious diseases, launches & approvals for INAAT products and availability of funding for diagnostic tools are various factors projected to drive the growth of the isothermal nucleic acid amplification technology market.
LAMP segment accounted for the largest share of the INAAT market
Based on technology, the isothermal nucleic acid amplification technology market is segmented into loop-mediated isothermal amplification (LAMP), transcription-mediated amplification (TMA), strand displacement amplification (SDA), nicking enzyme amplification reaction (NEAR), single-primer isothermal amplification (SPIA), and other technologies. In 2022, the loop-mediated isothermal amplification (LAMP) segment dominated the market. This is owing to high demand for LAMP kits and wide availability of these kits in developed and developing markets across the globe.
Infectious disease diagnosis segment accounted for the largest application segment of the market
Based on application, the INAAT market is segmented into infectious disease diagnosis, blood screening, and other applications. The disease diagnosis segment is expected to dominate the market in 2022. Various factors drive the growth of the segment are rising number of HIV, influenza, and hepatitis cases across the globe, focus on infectious disease control, and use of INAAT based kits for the diagnosis of these diseases.

The prominent players in isothermal nucleic acid amplification technology market are Grifols, S.A. (Spain), Hologic, Inc. (US), Abbott Laboratories (US), Becton, Dickinson and Company (US), Meridian Bioscience (US), Eiken Chemical Co., Ltd. (Japan), bioMérieux SA (France), Tecan Trading AG (Switzerland), New England Biolabs (US), QIAGEN N.V. (Germany), DiaSorin S.p.A. (Italy), General Electric (US), OptiGene Limited (UK), Quidel Corporation (US), Thermo Fisher Scientific (US), Genomtec (Poland), Mast Group Ltd. (UK), Ustar Biotechnologies (China), Jena Bioscience GmbH (Germany), Atila BioSystems (US), TwistDx Limited (UK), LGC Limited (UK), Life Sciences Advanced Technologies (US), GenoSensor Corporation (US), and PCR Biosystems (UK).

“North America: Accounted for the largest share in isothermal nucleic acid amplification technology market”
North America has the largest share of the isothermal nucleic acid amplification technology market. Factors such as availability of research funding and the development of diagnostic industry, increasing importance of early diagnosis for patient with HIV, Hepatitis and Influenza, and developed healthcare infrastructure are the major factors driving the market growth.
The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Supply Side- 80% and Demand Side - 20%
• By Designation: Managers- 45%, CXOs and Director level - 30%, and Executives - 25%
• By Region: North America -20%, Europe -15%, Asia-Pacific -55%, RoW -10%
List of Companies Profiled in the Report:
• Grifols, S.A. (Spain)
• Hologic, Inc. (US)
• Abbott Laboratories (US)
• Becton, Dickinson and Company (US)
• Meridian Bioscience (US)
• Eiken Chemical Co., Ltd. (Japan)
• bioMérieux SA (France)
• Tecan Trading AG (Switzerland)
• New England Biolabs (US)
• QIAGEN N.V. (Germany)
• DiaSorin S.p.A. (Italy)
• General Electric (US)
• OptiGene Limited (UK)
• Quidel Corporation (US)
• Thermo Fisher Scientific (US)
• Genomtec (Poland)
• Mast Group Ltd. (UK)
• Ustar Biotechnologies (China)
• Jena Bioscience GmbH (Germany)
• Atila BioSystems (US)
• TwistDx Limited (UK)
• LGC Limited (UK)
• Life Sciences Advanced Technologies (US)
• GenoSensor Corporation (US)
• PCR Biosystems (UK)

Research Coverage:
This report provides a detailed picture of the isothermal nucleic acid amplification technology market. It aims at estimating the size and future growth potential of the market across different segments such as the product, application, end users and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall isothermal nucleic acid amplification technology market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, challenges, and opportunities.



ページTOPに戻る


Table of Contents

1 INTRODUCTION 34
1.1 STUDY OBJECTIVES 34
1.2 MARKET DEFINITION 34
1.2.1 INCLUSIONS & EXCLUSIONS 35
1.3 MARKET SCOPE 36
FIGURE 1 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SEGMENTATION 36
1.3.1 YEARS CONSIDERED 37
1.4 CURRENCY CONSIDERED 37
1.5 LIMITATIONS 37
1.6 STAKEHOLDERS 38
1.7 SUMMARY OF CHANGES 38
2 RESEARCH METHODOLOGY 39
2.1 RESEARCH APPROACH 39
FIGURE 2 RESEARCH DESIGN 39
2.1.1 PRIMARY RESEARCH 39
FIGURE 3 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: PRIMARY RESPONDENTS 40
2.2 MARKET ESTIMATION METHODOLOGY 40
FIGURE 4 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS, 2022 40
FIGURE 5 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2022 41
2.2.1 INSIGHTS FROM PRIMARY EXPERTS 42
FIGURE 6 MARKET SIZE VALIDATION FROM PRIMARY RESOURCES 42
2.3 MARKET GROWTH RATE PROJECTIONS 43
FIGURE 7 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: CAGR PROJECTIONS, 2023–2028 44
FIGURE 8 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET (DEMAND SIDE): GROWTH ANALYSIS OF DEMAND-SIDE FACTORS 44
2.4 DATA TRIANGULATION 45
FIGURE 9 DATA TRIANGULATION METHODOLOGY 45
2.5 RESEARCH ASSUMPTIONS 45
2.6 RISK ANALYSIS 46
2.7 RECESSION IMPACT 46
3 EXECUTIVE SUMMARY 48
FIGURE 10 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION) 48
FIGURE 11 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION) 49
FIGURE 12 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 49
FIGURE 13 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 50
FIGURE 14 GEOGRAPHICAL SNAPSHOT OF ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET 51
4 PREMIUM INSIGHTS 52
4.1 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET OVERVIEW 52
FIGURE 15 INCREASING PREVALENCE OF INFECTIOUS DISEASES TO DRIVE MARKET GROWTH 52
4.2 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT AND COUNTRY (2022) 53
FIGURE 16 ASSAYS, KITS, AND REAGENTS ACCOUNTED FOR LARGEST MARKET SHARE IN 2022 53
4.3 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SHARE, BY APPLICATION, 2023 VS. 2028 53
FIGURE 17 DISEASE DIAGNOSIS APPLICATION SEGMENT TO CONTINUE TO DOMINATE MARKET IN 2028 53
4.4 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 54
FIGURE 18 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 54
5 MARKET OVERVIEW 55
5.1 INTRODUCTION 55
5.2 MARKET DYNAMICS 55
FIGURE 19 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 55
TABLE 1 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 56
5.2.1 DRIVERS 56
5.2.1.1 Recent launches of INAAT consumables by prominent market players 56
5.2.1.2 Growing funding initiatives for molecular diagnostics & infectious disease diagnostics 57
5.2.1.3 High prevalence of infectious diseases 58
5.2.2 RESTRAINTS 58
5.2.2.1 Unfavorable reimbursement scenario for in vitro diagnostic tests 58
5.2.3 OPPORTUNITIES 59
5.2.3.1 INAAT tests as point-of-care tools 59
5.2.3.2 Start-ups focusing on INAAT 59
5.2.4 CHALLENGES 60
5.2.4.1 Dominance of PCR 60
5.3 PRICING ANALYSIS 60
TABLE 2 AVERAGE SELLING PRICE OF INAAT PRODUCTS, 2022 60
5.4 VALUE CHAIN ANALYSIS 61
FIGURE 20 VALUE CHAIN OF INAAT MARKET: MAXIMUM VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES 61
5.5 ECOSYSTEM ANALYSIS 62
FIGURE 21 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: ECOSYSTEM ANALYSIS 62
TABLE 3 SUPPLY CHAIN ECOSYSTEM 63
5.6 KEY CONFERENCES & EVENTS IN 2023–2024 63
TABLE 4 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: DETAILED LIST OF CONFERENCES & EVENTS 63
5.7 PORTER’S FIVE FORCES ANALYSIS 65
TABLE 5 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: PORTER’S FIVE FORCES ANALYSIS 65
5.7.1 THREAT FROM NEW ENTRANTS 65
5.7.2 THREAT FROM SUBSTITUTES 65
5.7.3 BARGAINING POWER OF BUYERS 65
5.7.4 BARGAINING POWER OF SUPPLIERS 65
5.7.5 DEGREE OF COMPETITION 66
5.8 KEY STAKEHOLDERS & BUYING CRITERIA 66
FIGURE 22 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF INAAT PRODUCTS 66
FIGURE 23 BUYING CRITERIA FOR INAAT PRODUCTS 66
5.9 PATENT ANALYSIS 67
FIGURE 24 PATENT APPLICATIONS RELATED TO ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, JANUARY 2012–DECEMBER 2022 67
5.10 REGULATORY ANALYSIS 67
TABLE 6 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 67
TABLE 7 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 68
TABLE 8 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 68
TABLE 9 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 68
5.10.1 NORTH AMERICA 69
5.10.1.1 US 69
5.10.1.2 Canada 69
5.10.2 EUROPE 69
TABLE 10 EUROPE: CLASSIFICATION OF DEVICES 69
5.10.3 ASIA PACIFIC 70
5.10.3.1 China 70
5.10.3.2 Japan 70
5.10.3.3 India 70
5.10.4 LATIN AMERICA 70
5.10.4.1 Brazil 70
5.10.4.2 Mexico 71
5.10.5 MIDDLE EAST 71
5.11 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 71
FIGURE 25 REVENUE SHIFT AND NEW REVENUE POCKETS 71
6 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT 72
6.1 INTRODUCTION 73
TABLE 11 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 73
6.2 ASSAYS, KITS, AND REAGENTS 73
6.2.1 GROWING AWARENESS OF INAAT TO DRIVE DEMAND FOR ASSAYS, KITS, AND REAGENTS 73
TABLE 12 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY ASSAYS, KITS, AND REAGENTS MARKET, BY REGION, 2021–2028 (USD MILLION) 74
TABLE 13 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY ASSAYS, KITS, AND REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 74
TABLE 14 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY ASSAYS, KITS, AND REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 74
TABLE 15 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY ASSAYS, KITS, AND REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 75
6.3 SYSTEMS 75
6.3.1 GROWING POPULARITY OF INAAT SYSTEMS TO SUPPORT MARKET GROWTH 75
TABLE 16 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 76
TABLE 17 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 76
TABLE 18 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 76
TABLE 19 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 77
7 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY 78
7.1 INTRODUCTION 79
TABLE 20 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGIES 79
TABLE 21 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 80
7.2 LOOP-MEDIATED ISOTHERMAL AMPLIFICATION (LAMP) 80
7.2.1 LAUNCH OF NEW LAMP DIAGNOSTIC KITS TO SUPPORT MARKET GROWTH 80
TABLE 22 LOOP-MEDIATED ISOTHERMAL AMPLIFICATION (LAMP) MARKET, BY REGION, 2021–2028 (USD MILLION) 81
TABLE 23 NORTH AMERICA: LOOP-MEDIATED ISOTHERMAL AMPLIFICATION (LAMP) MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 81
TABLE 24 EUROPE: LOOP-MEDIATED ISOTHERMAL AMPLIFICATION (LAMP) MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 82
TABLE 25 ASIA PACIFIC: LOOP-MEDIATED ISOTHERMAL AMPLIFICATION (LAMP) MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 82
7.3 TRANSCRIPTION-MEDIATED AMPLIFICATION (TMA) 82
7.3.1 GROWING EFFORTS TO DEVELOP TMA KITS TO BOOST GROWTH 82
TABLE 26 TRANSCRIPTION-MEDIATED AMPLIFICATION (TMA) MARKET, BY REGION, 2021–2028 (USD MILLION) 83
TABLE 27 NORTH AMERICA: TRANSCRIPTION-MEDIATED AMPLIFICATION (TMA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 83
TABLE 28 EUROPE: TRANSCRIPTION-MEDIATED AMPLIFICATION (TMA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 84
TABLE 29 ASIA PACIFIC: TRANSCRIPTION-MEDIATED AMPLIFICATION (TMA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 84
7.4 NICKING ENZYME AMPLIFICATION REACTION (NEAR) 84
7.4.1 RAPID IDENTIFICATION OF SMALL DNA OR RNA FRAGMENTS TO BOOST ADOPTION OF NEAR 84
TABLE 30 NICKING ENZYME AMPLIFICATION REACTION (NEAR) MARKET, BY REGION, 2021–2028 (USD MILLION) 85
TABLE 31 NORTH AMERICA: NICKING ENZYME AMPLIFICATION REACTION (NEAR) MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 85
TABLE 32 EUROPE: NICKING ENZYME AMPLIFICATION REACTION (NEAR) MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 86
TABLE 33 ASIA PACIFIC: NICKING ENZYME AMPLIFICATION REACTION (NEAR) MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 86
7.5 STRAND DISPLACEMENT AMPLIFICATION (SDA) 86
7.5.1 GROWING USE OF SDA IN RNA AMPLIFICATION TO PROPEL MARKET GROWTH 86
TABLE 34 STRAND DISPLACEMENT AMPLIFICATION (SDA) MARKET, BY REGION, 2021–2028 (USD MILLION) 87
TABLE 35 NORTH AMERICA: STRAND DISPLACEMENT AMPLIFICATION (SDA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 87
TABLE 36 EUROPE: STRAND DISPLACEMENT AMPLIFICATION (SDA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 88
TABLE 37 ASIA PACIFIC: STRAND DISPLACEMENT AMPLIFICATION (SDA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 88
7.6 HELICASE-DEPENDENT AMPLIFICATION (HDA) 88
7.6.1 USE OF THERMOSTABLE HELICASE ENZYMES INSTEAD OF HEAT TO BOOST DEMAND FOR HDA 88
TABLE 38 HELICASE-DEPENDENT AMPLIFICATION (HDA) MARKET, BY REGION, 2021–2028 (USD MILLION) 89
TABLE 39 NORTH AMERICA: HELICASE-DEPENDENT AMPLIFICATION (HDA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 89
TABLE 40 EUROPE: HELICASE-DEPENDENT AMPLIFICATION (HDA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 90
TABLE 41 ASIA PACIFIC: HELICASE-DEPENDENT AMPLIFICATION (HDA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 90
7.7 NUCLEIC ACID SEQUENCE-BASED AMPLIFICATION (NASBA) 90
7.7.1 ADVANTAGES OF NASBA OVER PCR TO BOOST ADOPTION IN CLINICAL SETTINGS 90
TABLE 42 NUCLEIC ACID SEQUENCE-BASED AMPLIFICATION (NASBA) MARKET, BY REGION, 2021–2028 (USD MILLION) 91
TABLE 43 NORTH AMERICA: NUCLEIC ACID SEQUENCE-BASED AMPLIFICATION (NASBA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 91
TABLE 44 EUROPE: NUCLEIC ACID SEQUENCE-BASED AMPLIFICATION (NASBA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 92
TABLE 45 ASIA PACIFIC: NUCLEIC ACID SEQUENCE-BASED AMPLIFICATION (NASBA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 92
7.8 SINGLE-PRIMER ISOTHERMAL AMPLIFICATION (SPIA) 92
7.8.1 USE OF RNA/DNA-3′ PRIMER FOR FIRST-STRAND CDNA SYNTHESIS TO DRIVE MARKET 92
TABLE 46 SINGLE-PRIMER ISOTHERMAL AMPLIFICATION (SPIA) MARKET, BY REGION, 2021–2028 (USD MILLION) 93
TABLE 47 NORTH AMERICA: SINGLE-PRIMER ISOTHERMAL AMPLIFICATION (SPIA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 93
TABLE 48 EUROPE: SINGLE-PRIMER ISOTHERMAL AMPLIFICATION (SPIA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 94
TABLE 49 ASIA PACIFIC: SINGLE-PRIMER ISOTHERMAL AMPLIFICATION (SPIA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 94
7.9 OTHER TECHNOLOGIES 95
TABLE 50 OTHER INAAT TECHNOLOGIES MARKET, BY REGION, 2021–2028 (USD MILLION) 95
TABLE 51 NORTH AMERICA: OTHER INAAT TECHNOLOGIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 95
TABLE 52 EUROPE: OTHER INAAT TECHNOLOGIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 96
TABLE 53 ASIA PACIFIC: OTHER INAAT TECHNOLOGIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 96
8 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION 97
8.1 INTRODUCTION 98
TABLE 54 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 98
8.2 DISEASE DIAGNOSIS 98
TABLE 55 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 98
TABLE 56 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 99
TABLE 57 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 99
TABLE 58 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 99
TABLE 59 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 100
8.2.1 COVID-19 100
8.2.1.1 Extensive use of INAAT kits for COVID-19 diagnosis to support market growth 100
TABLE 60 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR COVID-19 TESTING, BY REGION, 2021–2028 (USD MILLION) 101
TABLE 61 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR COVID-19 TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 101
TABLE 62 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR COVID-19 TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 101
TABLE 63 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR COVID-19 TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 102
8.2.2 HEPATITIS 102
8.2.2.1 Growing adoption of advanced technologies for diagnosis of hepatitis B to drive growth 102
FIGURE 26 NEW CASES OF HEPATITIS B AND HEPATITIS C WORLDWIDE, BY GENDER, 2020 102
TABLE 64 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HEPATITIS TESTING, BY REGION, 2021–2028 (USD MILLION) 103
TABLE 65 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HEPATITIS TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 103
TABLE 66 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HEPATITIS TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 103
TABLE 67 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HEPATITIS TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 104
8.2.3 CT/NG 104
8.2.3.1 Growing prevalence of CT/NG infections worldwide to boost market 104
TABLE 68 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR CT/NG TESTING, BY REGION, 2021–2028 (USD MILLION) 105
TABLE 69 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR CT/NG TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 105
TABLE 70 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR CT/NG TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 105
TABLE 71 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR CT/NG TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 106
8.2.4 INFLUENZA 106
8.2.4.1 Growing focus on containing spread of influenza to propel growth 106
TABLE 72 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR INFLUENZA TESTING, BY REGION, 2021–2028 (USD MILLION) 106
TABLE 73 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR INFLUENZA TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 107
TABLE 74 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR INFLUENZA TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 107
TABLE 75 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR INFLUENZA TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 107
8.2.5 HIV 108
8.2.5.1 High global incidence of HIV to support market growth 108
TABLE 76 GLOBAL HIV CASES, 2021 108
TABLE 77 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HIV TESTING, BY REGION, 2021–2028 (USD MILLION) 108
TABLE 78 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HIV TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 109
TABLE 79 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HIV TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 109
TABLE 80 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HIV TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 109
8.2.6 OTHER DISEASES 110
TABLE 81 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER DISEASES, BY REGION, 2021–2028 (USD MILLION) 110
TABLE 82 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER DISEASES, BY COUNTRY, 2021–2028 (USD MILLION) 110
TABLE 83 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER DISEASES, BY COUNTRY, 2021–2028 (USD MILLION) 111
TABLE 84 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER DISEASES, BY COUNTRY, 2021–2028 (USD MILLION) 111
8.3 BLOOD SCREENING 111
8.3.1 INCREASING NUMBER OF BLOOD DONATIONS AND TRANSFUSIONS TO INCREASE USE OF INAAT IN BLOOD SCREENING APPLICATIONS 111
TABLE 85 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR BLOOD SCREENING APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 112
TABLE 86 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR BLOOD SCREENING APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 112
TABLE 87 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR BLOOD SCREENING APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 113
TABLE 88 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR BLOOD SCREENING APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 113
8.4 OTHER APPLICATIONS 113
TABLE 89 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 114
TABLE 90 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 114
TABLE 91 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 114
TABLE 92 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 115
9 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER 116
9.1 INTRODUCTION 117
TABLE 93 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION) 117
9.2 HOSPITALS 117
9.2.1 HOSPITALS TO DOMINATE INAAT MARKET DURING FORECAST PERIOD 117
TABLE 94 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HOSPITALS, BY REGION, 2021–2028 (USD MILLION) 118
TABLE 95 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION) 118
TABLE 96 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION) 118
TABLE 97 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION) 119
9.3 REFERENCE LABORATORIES 119
9.3.1 AVAILABILITY OF WIDE RANGE OF TEST PANELS FOR INFECTIOUS DISEASE TESTING TO SUPPORT MARKET 119
TABLE 98 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR REFERENCE LABORATORIES, BY REGION, 2021–2028 (USD MILLION) 119
TABLE 99 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 120
TABLE 100 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 120
TABLE 101 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 120
9.4 ACADEMIC & RESEARCH INSTITUTES 121
9.4.1 GROWING USE OF INAAT ASSAYS BY ACADEMIC & RESEARCH INSTITUTES TO BOOST MARKET 121
TABLE 102 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION) 121
TABLE 103 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 121
TABLE 104 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 122
TABLE 105 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 122
9.5 OTHER END USERS 122
TABLE 106 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION) 123
TABLE 107 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 123
TABLE 108 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 123
TABLE 109 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 124
10 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY REGION 125
10.1 INTRODUCTION 126
TABLE 110 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY REGION, 2021–2028 (USD MILLION) 126
10.2 NORTH AMERICA 126
FIGURE 27 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SNAPSHOT 127
TABLE 111 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 127
TABLE 112 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 128
TABLE 113 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 128
TABLE 114 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 129
TABLE 115 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 129
TABLE 116 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION) 129
10.2.1 US 130
10.2.1.1 Increasing approvals of INAAT products to drive market growth 130
TABLE 117 US: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 130
TABLE 118 US: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 131
TABLE 119 US: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 131
TABLE 120 US: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 132
TABLE 121 US: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION) 132
10.2.2 CANADA 132
10.2.2.1 Growing demand for molecular diagnostic kits to boost adoption of INAAT 132
TABLE 122 CANADA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 133
TABLE 123 CANADA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 133
TABLE 124 CANADA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 134
TABLE 125 CANADA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 134
TABLE 126 CANADA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION) 134
10.2.3 NORTH AMERICA: RECESSION IMPACT 135
10.3 EUROPE 135
TABLE 127 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 136
TABLE 128 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 136
TABLE 129 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 137
TABLE 130 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 137
TABLE 131 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 138
TABLE 132 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION) 138
10.3.1 GERMANY 138
10.3.1.1 Germany to dominate European isothermal nucleic acid amplification technology market during forecast period 138
TABLE 133 GERMANY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 139
TABLE 134 GERMANY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 140
TABLE 135 GERMANY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 140
TABLE 136 GERMANY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 141
TABLE 137 GERMANY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION) 141
10.3.2 UK 141
10.3.2.1 Growing adoption of INAAT products to support market growth in UK 141
TABLE 138 NUMBER OF BLOOD DONATIONS IN UK, 2016–2020 142
TABLE 139 UK: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 142
TABLE 140 UK: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 143
TABLE 141 UK: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 143
TABLE 142 UK: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 144
TABLE 143 UK: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION) 144
10.3.3 FRANCE 144
10.3.3.1 Established blood screening regulations to boost growth 144
TABLE 144 HIV DATA FOR FRANCE, 2021 145
TABLE 145 FRANCE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 145
TABLE 146 FRANCE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 145
TABLE 147 FRANCE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 146
TABLE 148 FRANCE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 146
TABLE 149 FRANCE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION) 146
10.3.4 ITALY 147
10.3.4.1 Favorable government initiatives for blood transfusion to support growth 147
TABLE 150 HIV DATA FOR ITALY, 2021 147
TABLE 151 ITALY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 148
TABLE 152 ITALY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 148
TABLE 153 ITALY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 149
TABLE 154 ITALY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 149
TABLE 155 ITALY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION) 149
10.3.5 SPAIN 150
10.3.5.1 Growing demand for diagnostic testing in Spain to favor market growth 150
TABLE 156 HIV DATA FOR SPAIN, 2021 150
TABLE 157 SPAIN: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 151
TABLE 158 SPAIN: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 151
TABLE 159 SPAIN: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 152
TABLE 160 SPAIN: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 152
TABLE 161 SPAIN: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION) 152
10.3.6 REST OF EUROPE 153
TABLE 162 REST OF EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 153
TABLE 163 REST OF EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 154
TABLE 164 REST OF EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 154
TABLE 165 REST OF EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 155
TABLE 166 REST OF EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION) 155
10.3.7 EUROPE: RECESSION IMPACT 155

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（バイオ薬物）の最新刊レポート

MarketsandMarkets社のBiotechnology分野での最新刊レポート

本レポートと同じKEY WORD（nucleic）の最新刊レポート


よくあるご質問


MarketsandMarkets社はどのような調査会社ですか?


マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/12/20　10:28

158.95 円

165.20 円

201.28 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.